Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.019 | 0.7 |
mRNA | 3-Cl-AHPC | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.011 | 0.7 |
mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.01 | 0.7 |
mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | -0.0099 | 0.7 |